Financials Avinger, Inc.

Equities

AVGR

US0537348775

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:30:00 2024-04-26 pm EDT 5-day change 1st Jan Change
3.73 USD -5.08% Intraday chart for Avinger, Inc. -5.09% +37.64%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 11.8 37.37 43 8.068 3.469 5.918 - -
Enterprise Value (EV) 1 11.8 37.37 35.79 8.068 3.469 5.918 5.918 5.918
P/E ratio -0.36 x -0.96 x -1.97 x -0.25 x -0.12 x -1.79 x -2.76 x -4.34 x
Yield - - - - - - - -
Capitalization / Revenue 1.29 x 4.27 x 4.25 x - 0.45 x 0.56 x 0.42 x 0.33 x
EV / Revenue 1.29 x 4.27 x 4.25 x - 0.45 x 0.56 x 0.42 x 0.33 x
EV / EBITDA - -2,492,604 x -2,622,336 x - - - - -
EV / FCF - - -2,733,690 x - - - - -
FCF Yield - - -0% - - - - -
Price to Book - - 4.42 x - - - - -
Nbr of stocks (in thousands) 34.5 283 319 496 1,280 1,586 - -
Reference price 2 342.0 132.0 135.0 16.27 2.710 3.730 3.730 3.730
Announcement Date 3/5/20 3/11/21 3/22/22 3/15/23 3/20/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 9.131 8.761 10.13 - 7.652 10.5 13.93 17.8
EBITDA - -14.99 -16.4 - - - - -
EBIT 1 -19.36 -17.4 -18.1 - -16.64 -16.28 -14.26 -12.27
Operating Margin -212.01% -198.65% -178.69% - -217.39% -155.07% -102.37% -68.9%
Earnings before Tax (EBT) 1 -19.45 -19.01 -17.41 - -18.32 -16.28 -14.26 -12.27
Net income 1 -23.03 -22.87 -21.59 -27.24 -18.32 -16.28 -14.26 -12.27
Net margin -252.22% -261.07% -213.1% - -239.41% -155.07% -102.37% -68.9%
EPS 2 -954.0 -138.0 -68.55 -65.40 -23.31 -2.080 -1.350 -0.8600
Free Cash Flow - - -15.73 - - - - -
FCF margin - - -155.29% - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 3/5/20 3/11/21 3/22/22 3/15/23 3/20/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 2.366 2.403 1.888 2.132 1.888 2.041 1.817 1.906 2.36 2.551 2.726 2.859 3.1
EBITDA -4.092 -4.339 -4.629 -3.659 - - - - - - - - -
EBIT 1 -4.489 -4.556 -4.696 -3.759 - - -4.033 -4.615 -4.498 -4.038 -3.921 -3.819 -
Operating Margin -189.73% -189.6% -248.73% -176.31% - - -221.96% -242.13% -190.59% -158.29% -143.84% -133.58% -
Earnings before Tax (EBT) 1 -4.912 -4.996 -5.14 -4.214 - - -4.476 -5.024 -4.498 -4.038 -3.921 -3.819 -
Net income 1 -5.956 -6.039 -11.38 -5.341 - - -2.04 -5.024 -4.498 -4.038 -3.921 -3.819 -
Net margin -251.73% -251.31% -602.65% -250.52% - - -112.27% -263.59% -190.59% -158.29% -143.84% -133.58% -
EPS 2 -18.00 -18.90 -34.95 -14.10 -10.65 -8.850 -2.920 -3.930 -1.350 -0.4300 -0.4200 0.1300 -0.4000
Dividend per Share - - - - - - - - - - - - -
Announcement Date 11/11/21 3/22/22 5/10/22 8/11/22 5/10/23 7/27/23 10/26/23 3/20/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - 7.21 - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - -15.7 - - - - -
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - 30.50 - - - - -
Cash Flow per Share - - - - - - - -
Capex 0.09 - 0.03 - - - - -
Capex / Sales 0.96% - 0.34% - - - - -
Announcement Date 3/5/20 3/11/21 3/22/22 3/15/23 3/20/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.73 USD
Average target price
5 USD
Spread / Average Target
+34.04%
Consensus
  1. Stock Market
  2. Equities
  3. AVGR Stock
  4. Financials Avinger, Inc.